Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 12, 2015 07:00 ET | Source: MannKind

MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO

VALENCIA, Calif., Jan. 12, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), a biopharmaceutical-based technology company, today announced that Alfred Mann, the company's founder, retired...
January 08, 2015 07:00 ET | Source: MannKind

MannKind Earns $50 Million in Milestone Payments From Sanofi

VALENCIA, Calif., Jan. 8, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that it has earned a total of $50 million in milestone payments in connection with the...
January 07, 2015 17:00 ET | Source: MannKind

MannKind Corporation to Present at the J.P. Morgan 2015 Healthcare Conference

VALENCIA, Calif., Jan. 7, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that it...
November 25, 2014 17:00 ET | Source: MannKind

MannKind Corporation to Present at The 26th Annual Piper Jaffray Healthcare Conference

VALENCIA, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that...
November 03, 2014 09:00 ET | Source: MannKind

MannKind Corporation Reports 2014 Third Quarter Financial Results

VALENCIA, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the third quarter ended September 30, 2014. For the third quarter of 2014,...
October 27, 2014 17:00 ET | Source: MannKind

MannKind Corporation to Hold 2014 Third Quarter Financial Results Conference Call on November 3, 2014

VALENCIA, Calif., Oct. 27, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2014 third quarter financial results on Monday, November 3, 2014 and its management will host a...
September 29, 2014 19:29 ET | Source: MannKind

MannKind Announces Receipt of $150 Million Licensing Upfront Payment

VALENCIA, Calif., Sept. 29, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that it had received a $150 million upfront payment in connection with an exclusive worldwide...
September 24, 2014 17:00 ET | Source: MannKind

MannKind Announces Closing of Global Licensing Agreement With Sanofi

VALENCIA, Calif., Sept. 24, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced the closing of a worldwide exclusive collaboration and licensing agreement with Sanofi for...
September 02, 2014 17:00 ET | Source: MannKind

MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference

VALENCIA, Calif., Sept. 2, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that...
August 11, 2014 09:00 ET | Source: MannKind

MannKind Corporation Reports 2014 Second Quarter Financial Results

VALENCIA, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the second quarter ended June 30, 2014. For the second quarter of 2014,...